Andreas Nitsche

5 ta ish

Robert Koch Institute

1. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

   Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder +10

   Maqola202010 iqtibos

   ABIABI:AkademIndex/2026.other.508188

2. Guideline to reference gene selection for quantitative real-time PCR

   Aleksandar Radonić, Stefanie Thulke, Ian M Mackay +3

   Maqola20033 iqtibos

   ABIABI:AkademIndex/2026.other.063210

3. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

   Jenny Meinhardt, Josefine Radke, Carsten Dittmayer +40

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.647885

4. Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies

   Rachel L. Roper, Alfredo Garzino‐Demo, Carlos del Rı́o +24

   Sharh maqola20232 iqtibos

   ABIABI:AkademIndex/2026.other.300193

5. Lateral flow–based nucleic acid detection of SARS-CoV-2 using enzymatic incorporation of biotin-labeled dUTP for POCT use

   Saloni Agarwal, Christian Warmt, Joerg Henkel +3

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.377818